Research and Development

Showing 15 posts of 9594 posts found.

gilham_low_res_horizon

Ian Gilham appointed chairman of the board at Horizon Discovery





January 17, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development Gilham, Horizon Discovery

Research tools firm Horizon Discovery has appointed Dr Ian Gilham as chairman of its board of directors.



  Gilham’s healthcare industry …
NHS image

Gene trial ‘restores sight’

January 17, 2014 Research and Development, Sales and Marketing NHS, Oxford University Hospitals NHS Trust, choroideremia, eyes

A UK Phase I trial of a gene therapy designed to restore sight in patients suffering from an inherited form …
tim_tasker_heptares

Heptares appoints Tim Tasker as chief medical officer



January 16, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Heptares, tim tasker

Drug development firm Heptares Therapeutics has appointed Dr Tim Tasker as its chief medical officer (CMO) and VP of Development. …
stevecutler_icon

ICON hires Dr Steve Cutler as chief operating officer

January 15, 2014 Manufacturing and Production, Research and Development, Sales and Marketing ICON, cutler

Clinical research organisation ICON has appointed Dr Steve Cutler to the newly created position of chief operating officer (COO).

UK cancer figures rise

January 15, 2014 Research and Development, Sales and Marketing Cancer, England, NHS, research uk

More people are being diagnosed with cancer than ever before, according to figures from Cancer Research UK – as an …
Bayer image

Bayer and Regeneron to co-develop wet AMD antibody

January 14, 2014 Research and Development, Sales and Marketing Bayer, Eylea, Regeneron, pdgfr-beta, wet AMD

Bayer and Regeneron are co-developing an antibody to the Platelet Derived Growth Factor Receptor Beta (PDGFR-beta) as a combination therapy …
gsk image

FDA approves GSK cancer combo

January 14, 2014 Research and Development, Sales and Marketing FDA, GSK, Tafinlar, mekinist

US regulators have shown the green light to a combination of two GlaxoSmithKline skin cancer drugs, Mekinist and Tafinlar, to …
Sanofi image

Sanofi signs new genetics deal with Isarna

January 14, 2014 Manufacturing and Production, Research and Development, Sales and Marketing DNA, RNA, Sanofi, aso, isarna

Sanofi has agreed to produce genetic compounds developed by German biotech Isarna Therepeutics to accelerate their progress to the clinical …

Incyte names former Novartis president as its chief executive

January 14, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Incyte, Novartis, hoppenot

Biopharma firm Incyte has announced that the former president of Novartis Oncology has been named as its president and chief …

New managing director for Boehringer Ingelheim UK

January 13, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, krumins

Zinta Krumins has been appointed as the managing director of Boehringer Ingelheim UK & Ireland. The appointment will present a …
Sanofi image

Sanofi pays $700m to expand rare disease portfolio

January 13, 2014 Research and Development, Sales and Marketing Alnylam, Sanofi, rare sidease

Sanofi and Alnylam have announced the expansion of their 2012 agreement to develop and sell treatments for rare genetic diseases. …
maze image

Thought leader mapping: do we need a radical rethink?

January 13, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Havas, bartley, marketing, sales, thought leader

The effectiveness of healthcare communications is often more reliant on who’s delivering the message than the content of the message …
john_milad

New chief executive for Quanta Fluid Solutions

January 13, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing milad, quanta

Medical devices firm Quanta Fluid Solutions has announced the appointment of John Milad as chief executive. Milad’s career spans 20 …

Chris Kilbee appointed Group director of UBM Pharma Portfolio



January 10, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPhI, UBM pharma, amsterdam

Amsterdam: CPhI, part of UBM Live, has announced the appointment of Chris Kilbee to the role of Group director of …
David Taylor image

UK cancer death rate could be halved by 2030

January 10, 2014 Research and Development, Sales and Marketing Cancer, Taylor, UCL, wardle

 British cancer deaths could drop 50% by 2030 if early diagnosis and improved treatment policies are put in place academics …
The Gateway to Local Adoption Series

Latest content